An outbreak of infection due to β-lactamase Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae in a Greek university hospital: Molecular characterization, epidemiology, and outcomes

Clinical Infectious Diseases

Volumn 50, Issue 3, 2010, Pages 364-373

  Souli, Maria ^a   Galani, Irene ^a   Antoniadou, Anastasia ^a   Papadomichelakis, Evangelos ^a   Poulakou, Garyphallia ^a   Panagea, Theofano ^a   Vourli, Sofia ^a   Zerva, Loukia ^a   Armaganidis, Apostolos ^a   Kanellakopoulou, Kyriaki ^a   Giamarellou, Helen ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; BETA LACTAMASE; BETA LACTAMASE CTX M 15; BETA LACTAMASE LEN 19; BETA LACTAMASE SHV; BETA LACTAMASE SHV 11; BETA LACTAMASE SHV 12; BETA LACTAMASE TEM 1; BORONIC ACID DERIVATIVE; CARBAPENEM; CARBAPENEMASE; CARBAPENEMASE 2; CEPHALOSPORIN DERIVATIVE; COLISTIN; EDETIC ACID; FOSFOMYCIN; GENTAMICIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; TIGECYCLINE; UNCLASSIFIED DRUG;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDEMIC; FEMALE; GENE SEQUENCE; GREECE; HUMAN; INTENSIVE CARE UNIT; ISOELECTRIC FOCUSING; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; LOWER RESPIRATORY TRACT INFECTION; MALE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; MOLECULAR TYPING; MORTALITY; MULTIDRUG RESISTANCE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SURGICAL INFECTION; UNIVERSITY HOSPITAL; URINARY TRACT INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; DISEASE OUTBREAKS; DNA FINGERPRINTING; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; GREECE; HOSPITALS, UNIVERSITY; HUMANS; INTENSIVE CARE UNITS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; TREATMENT OUTCOME;

EID: 75749083649     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/649865     Document Type: Article

References (35)

1. Greek System for the Surveillance of Antimicrobial Resistance. Available at: http://www.mednet.gr/whonet. Accessed 30 June 2009.
2. Giakkoupi P, Xanthaki A, Kanelopoulou M, et al. VIM-1 metallo- βlactamase-producing Klebsiella pneumoniae strains in Greek hospitals. J Clin Microbiol 2003;41:3893-3896.
3. VIM-L metallo -β- lactamase gene. J Clin Microbiol 2005;43:5344-5347.
4. Souli M, Kontopidou FV, Fapadomichelakis E, Galani I, Armaganidis A, Giamarellou H. Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-beta-lactamase in a Greek university hospital. Clin Infect Dis 2008;46:847-854.
5. VIM-L positive Klebsiella pneumoniae in Athens, Greece: a prospective survey. J Antimicrob Chemother 2008;61:59-63.
6. Vatopoulos A. High rates of metallo-beta-Iactamase-producing Klebsiella pneumoniae in Greece: a review of the current evidence. Euro Surveill 2008;13:1-6.
7. Cuzon G, Naas T, Demachy MC, Nordmann P. Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece. Antimicrob Agents Chemother 2008;52:796-797.
8. Tegmark Wisell K, Haeggman S, Gezelius L, et al. Identification of Klebsiella pneumoniae carbapenemase in Sweden. Euro Surveill 2007;12(12): E071220.3.
9. Maltezou HC, Giakkoupi P, Maragos A, et al. Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece). J Infect 2009;58:213-219.
10. Pournaras S, Protonotariou E, Voulgari E, et al. Clonal spread of KPC2 carbapenemase-producing Klebsiella pneumoniae strains in Greece. J Antimicrob Chemother 2009;64:348-352.
11. Giakoupi P, Maltezou H, Polemis M, Pappa O, Saroglou G, Vatopoulos A; Greek System for the Surveillance of Antimicrobial Resistance. KPC2-produdng Klebsiella pneumoniae infections in Greek hospitals are mainly due to a hyperepidemic clone. Euro Surveill 2009;14:19218
12. Kitchel B, Rasheed JK, Patel JB, et al. Molecular epidemiology of KPCprodudng Klebsiella pneumoniae in the United States: clonal expansion of MLST sequence type 258. Antimicrob Agents Chemother 2009;53: 3365-3370.
13. Samuelsen O, Naseer U, Tofteland S, et al. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmidmediated KPC carbapenemase in Norway and Sweden. J Antimicrob Chemother 2009;63:654-658.
14. Papadomichelakis E, Kontopidou F, Antoniadou A, et al. Screening for resistant gram-negative microorganisms to guide empiric therapy of subsequent infection. Intensive Care Med 2008;34:2169-2175.
15. American Thoracic Society Documents. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388416.
16. Calandra T, Cohen J; International Sepsis Forum. Definition of infection in the ICU consensus conference. The International Sepsis Forum Consensus Conference on Definitions of Infection in the ICU. Crit Care Med 2005;33:1538-1548.
17. Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001;32: 1249-1272. (Pubitemid 32405897)
18. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36: 309-332. (Pubitemid 351763841)
19. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-874.
20. Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. CLSI document M100-S19. Wayne, PA: Clinical Laboratory Standards Institute, 2009.
21. European Committee on Antimicrobial Susceptibility Testing. Clinical breakpoints. Available at: http://www.srga.org/eucastwt/MICTAB/index.html. Accesed 10 June 2009.
22. Lee K, Chong Y, Shin HB, et al. Modified Hodge and EDTA-disk synergy tests to screen metallo-b-lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin Microbiol Infect 2001;7:88-91.
23. Tsakris A, Kristo I, Poulou A, et al. Evaluation of boronic acid disk tests for differentiating KPC-possessing Klebsiella pneumoniae in the clinical laboratory. J Clin Microbiol 2009;47:362-367.
24. Bradford PA, Bratu S, Urban C, et al. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 β-lactamases in New York City. Clin Infect Dis 2004;39:55-60.
25. Galani I, Xirouchaki E, Kanellakopoulou K, et al. Transferable plasmid mediating resistance to multiple antimicrobial agents in Klebsiella pneumoniae isolates in Greece. Clin Microbiol Infect 2002;8:579-588.
26. Dutour C, Bonnet R, Marchandin H, et al. CTX-M-1, CTX-M-3, and CTX-M-14 β-lactamases from Enterobacteriaceae isolated in France. Antimicrob Agents Chemother 2002;46:534-537.
27. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field-gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233-2239.
28. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-829.
29. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008;52:1028-1033.
30. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP.Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008;29:1099-1106.
31. Leavitt A, Navon-Venezia S, Chmelnitsky I, Schwaber MJ, Carmeli Y. Emergence of KPC-2 and KPC-3 in carbapenem-resistant. Klebsiella pneumoniae strains in an Israeli hospital. Antimicrob Agents Chemother 2007;51:3026-3029.
32. Woodford N, Tierno PM Jr, Young K, et al. Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A β-lactamase, KPC-3, in a New York medical center. Antimicrob Agents Chemother 2004;48:4793-4799.
33. Bratu S, Mooty M, Nichani S, et al. Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection. Antimicrob Agents Chemother 2005;49: 3018-3020.
34. Peirano G, Seki LM, Val Passos VL, Pinto MC, Guerra LR, Asensi MD. Carbapenem-hydrolysing b-lactamase KPC-2 in Klebsiella pneumoniae isolated in Rio de Janeiro, Brazil. J Antimicrob Chemother 2009;63: 265-268.
35. Cai JC, Zhou HW, Zhang R, Chen GX. Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli isolates possessing the plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC-2 in intensive care units of a Chinese hospital. Antimicrob Agents Chemother 2008;52:2014-2018.